Home : FDA Drug Database : Avandaryl : News Articles
Avandaryl - News Articles
-
Jul 30, 2007
Forbes, NY -
The Avandia family of drugs, which includes Avandamet and Avandaryl, posted sales of $2.2 billion last year. Despite declining sales of its second best-selling product, GlaxoSmithKline's second-quarter pharmaceutical sales were even with those a year ago, thanks to increased sales of other ... -
Jul 31, 2007
Forbes, NY -
Sales of Avandia and the combination products Avandamet and Avandaryl fell 22 percent to 349 million pounds, or $708.9 million, during the second quarter. ... -
Jul 25, 2007
Wall Street Journal -
but derives the bulk of its sales from the US Sales for the Avandia family of drugs, which also include combination products Avandamet and Avandaryl, fell 22% to £349 million. Avandia has been hit by concerns about possible cardiovascular side effects linked to the ...
-
Jul 25, 2007
Forbes, NY -
The Avandia family of drugs, which includes combination treatments Avandamet and Avandaryl, last year posted sales of 1.6 billion pounds, making it GlaxoSmithKline (nyse: GSK ... -
Jul 31, 2007
The Herald, UK -
Sales for the Avandia family of drugs, which also include combination products Avandamet and Avandaryl, fell 22% to £349m in the quarter that ended June 30. Sales took a dive after an article published in the New England Journal of Medicine in May raised concerns ... -
Jul 31, 2007
Telegraph.co.uk, United Kingdom -
Along with Avandia, GSK sells two other combination drugs under the brand names Avandamet and Avandaryl that include the same active ingredient as is in Avandia. The class of drugs are GSK's number two best-seller. GSK said last week that sales of the ...






